Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Miyachi

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2004
[Design and synthesis of subtype- and species-selective peroxisome proliferator-activated receptor (PPAR) alpha ligands]Hiroyuki Miyachi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2010
[PPARgamma targeted genome-based drug discovery; present and future direction]Hiroyuki Miyachi
Current Medicinal Chemistry|September 28, 2007
Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR) delta-selective ligandsHiroyuki Miyachi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 30, 2022
[Attempt to Create a Drug for Treatment of Fibrotic Diseases Based on the Non-genomic Action of Nuclear Receptors]Hiroyuki Miyachi
International Journal of Molecular Sciences|September 10, 2021
Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated ReceptorsHiroyuki Miyachi
Idrugs : the Investigational Drugs Journal|August 31, 2004
Recent progress in research on peroxisome proliferator-activated receptor alpha-selective ligandsHiroyuki Miyachi
International Journal of Molecular Sciences|February 25, 2023
Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to AntagonistHiroyuki Miyachi
PPAR Research|June 21, 2008
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile TemplateHiroyuki Miyachi, Yuichi Hashimoto
Chemical & Pharmaceutical Bulletin|August 23, 2002
Biomimetic oxidation of 2-methylimidazole derivative with a chemical model system for cytochrome P-450Hiroyuki Miyachi, Yoshio Nagatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[PPARs as molecular targets for drug discovery]Hiroyuki Kagechika, Hiroyuki Miyachi
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2004
[Design and synthesis of subtype- and species-selective peroxisome proliferator-activated receptor (PPAR) alpha ligands]Hiroyuki Miyachi
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2010
[PPARgamma targeted genome-based drug discovery; present and future direction]Hiroyuki Miyachi
Current Medicinal Chemistry|September 28, 2007
Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR) delta-selective ligandsHiroyuki Miyachi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 30, 2022
[Attempt to Create a Drug for Treatment of Fibrotic Diseases Based on the Non-genomic Action of Nuclear Receptors]Hiroyuki Miyachi
International Journal of Molecular Sciences|September 10, 2021
Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated ReceptorsHiroyuki Miyachi
Idrugs : the Investigational Drugs Journal|August 31, 2004
Recent progress in research on peroxisome proliferator-activated receptor alpha-selective ligandsHiroyuki Miyachi
International Journal of Molecular Sciences|February 25, 2023
Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to AntagonistHiroyuki Miyachi
PPAR Research|June 21, 2008
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile TemplateHiroyuki Miyachi, Yuichi Hashimoto
Chemical & Pharmaceutical Bulletin|August 23, 2002
Biomimetic oxidation of 2-methylimidazole derivative with a chemical model system for cytochrome P-450Hiroyuki Miyachi, Yoshio Nagatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[PPARs as molecular targets for drug discovery]Hiroyuki Kagechika, Hiroyuki Miyachi
Pageof 12